The potassium channel KCa3.1 represents a valid pharmacological target for microgliosis-induced neuronal impairment in a mouse model of Parkinson’s disease
Cited by 43
Related Papers
TRPV1 sustains microglial metabolic reprogramming in Alzheimer's disease
|EMBO Reports|2021|115
A breakdown in microglial metabolic reprogramming causes internalization dysfunction of α-synuclein in a mouse model of Parkinson’s disease
|Journal of Neuroinflammation|2022|76
TRPV1 regulates ApoE4-disrupted intracellular lipid homeostasis and decreases synaptic phagocytosis by microglia
|Experimental & Molecular Medicine|2023|59
Ca2+-dependent endoplasmic reticulum stress correlation with astrogliosis involves upregulation of KCa3.1 and inhibition of AKT/mTOR signaling
|Journal of Neuroinflammation|2018|32
The TRPV1-PKM2-SREBP1 axis maintains microglial lipid homeostasis in Alzheimer’s disease
|Cell Death and Disease|2025|23